Breaking News Instant updates and real-time market news.

TSRO

Tesaro

$125.85

5.45 (4.53%)

08:04
08/25/17
08/25
08:04
08/25/17
08:04

Tesaro announces nine data presentations at ESMO meeting

TESARO announced that data from nine abstracts will be presented at the 2017 European Society for Medical Oncology annual meeting, September 8 to September 12, 2017, in Madrid. "We are excited that a wealth of data from the landmark ENGOT-OV16/NOVA trial will be presented at this year's ESMO Annual Meeting," said Mary Lynne Hedley, Ph.D., President and COO of TESARO. "Patient-reported quality of life data for patients treated with niraparib versus placebo will be featured in an oral presentation and the results of two post-hoc analyses, the observed exposure-response relationship of niraparib in gBRCAmut and non-gBRCAmut patients, and the safety and efficacy of niraparib in elderly patients, will be subjects for poster discussions. In addition, data from the Phase 1/2 trial of niraparib plus pembrolizumab in patients with triple-negative breast cancer or recurrent platinum-resistant ovarian cancer will be highlighted in a poster discussion. Finally, a poster will be presented detailing results from the Phase 1 study of TSR-042, our anti-PD-1 antibody."

  • 06

    Sep

  • 06

    Sep

  • 08

    Sep

  • 25

    Oct

TSRO Tesaro
$125.85

5.45 (4.53%)

08/17/17
BOFA
08/17/17
NO CHANGE
Target $59
BOFA
Tesaro and Clovis at BofA/Merrill
BofA/Merrill said it already assumed that the maintenance Ovarian cancer PARP market would be shared between Tesaro (TSRO), Clovis (CLVS), and AstraZeneca (AZN) and differences, combined with more nuanced differentiators in safety and dosing justify multiple participants. The firm's analyst reiterates Buy ratings on both Clovis and Tesaro and notes both have demonstrated strong initial uptake.
08/18/17
SBSH
08/18/17
NO CHANGE
Target $216
SBSH
Buy
Citi sees advantage for Tesaro despite broad Lynparza label
Citi analyst Robyn Karnauskas says the "broad label" given yesterday to AstraZeneca's (AZN) Lynparza increases competition for Tesaro (TSRO). Lynparza got a broad label in all ovarian cancer patients, which Karnauskas says she was not modeling for. The analyst suspects Clovis Oncology (CLVS) could also get a similar broad label. Nonetheless, she believes that with "better clinical data, better value, and dosing convenience," Tesaro's Zejula has a potential marketing advantage. Oncologic drugs with the best outcomes data eventually emerge market winners, Karnauskas tells investors in a research note. The analyst keeps a Buy rating on Tesaro with a $216 price target. The shares closed yesterday down $3.94 to $109.05.
08/18/17
LEER
08/18/17
NO CHANGE
Target $107
LEER
Outperform
Clovis price target lowered to $107 from $115 at Leerink
Leerink analyst Michael Schmidt lowered his price target for Clovis Oncology (CLVS) to $107 after competitor AstraZeneca (AZN) received a broad label for PARP inhibitor Lynparza as maintenance treatment following second line ovarian cancer therapy regardless of BRCA status. His new target reflects a three-way market split among Clovis' Rubraca, Tesaro's (TSRO) Zejula and Lynparza in second line ovarian cancer maintenance. The analyst, however, believes Clovis remains attractively valued and he keeps an Outperform rating on the shares.
08/18/17
FBCO
08/18/17
NO CHANGE
Target $190
FBCO
Outperform
Tesaro, Clovis shares reflect very little M&A value, says Credit Suisse
Credit Suisse analyst Alethia Young believes AstraZeneca's (AZN) broad label news yesterday for Lynparza likely lifted an overhang for both Tesaro (TSRO) and Clovis Oncology (CLVS). Shares of both Tesaro and Clovis are reflecting "very little to no M&A value" at current levels, Young tells investors in a research note. She lowered her price target for Tesaro to $190 from $198 and keeps an Outperform rating on the name.

TODAY'S FREE FLY STORIES

RDWR

Radware

$21.09

-0.25 (-1.17%)

10:01
02/21/18
02/21
10:01
02/21/18
10:01
Conference/Events
Radware management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 29

    Mar

QTWO

Q2 Holdings

$42.85

-1.8 (-4.03%)

10:00
02/21/18
02/21
10:00
02/21/18
10:00
Conference/Events
Q2 Holdings management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 15

    Mar

10:00
02/21/18
02/21
10:00
02/21/18
10:00
General news
U.S. Markit manufacturing PMI rose 0.4 points to 55.9 in the flash February »

U.S. Markit manufacturing…

LFUS

Littelfuse

$208.66

0.61 (0.29%)

09:59
02/21/18
02/21
09:59
02/21/18
09:59
Conference/Events
Littelfuse management to meet with Oppenheimer »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

NJDCY

Nidec

$37.80

-0.12 (-0.32%)

09:57
02/21/18
02/21
09:57
02/21/18
09:57
Conference/Events
Nidec management to meet with Oppenheimer »

Group luncheon to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

HDP

Hortonworks

$18.22

0.03 (0.16%)

09:55
02/21/18
02/21
09:55
02/21/18
09:55
Conference/Events
Hortonworks management to meet with Northland »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

  • 26

    Feb

  • 11

    Mar

  • 13

    Mar

  • 14

    Mar

  • 11

    Apr

  • 30

    May

PVG

Pretium Resources

$6.56

-0.05 (-0.76%)

09:55
02/21/18
02/21
09:55
02/21/18
09:55
Options
Pretium Resources put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Mar

  • 11

    Mar

AAP

Advance Auto Parts

$115.88

10.53 (10.00%)

, EXR

Extra Space Storage

$84.86

4.105 (5.08%)

09:55
02/21/18
02/21
09:55
02/21/18
09:55
Options
Early notable gainers among liquid option names on February 21st »

Notable gainers among…

AAP

Advance Auto Parts

$115.88

10.53 (10.00%)

EXR

Extra Space Storage

$84.86

4.105 (5.08%)

MOS

Mosaic

$27.48

0.72 (2.69%)

CF

CF Industries

$42.80

0.975 (2.33%)

VRSK

Verisk Analytics

$97.04

-1.75 (-1.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 25

    Feb

  • 25

    Feb

  • 28

    Feb

  • 30

    May

GVA

Granite Construction

$60.01

0.0066 (0.01%)

09:52
02/21/18
02/21
09:52
02/21/18
09:52
Conference/Events
Granite Construction management to meet with MKM Partners »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

  • 23

    May

CPS

Cooper-Standard

$120.74

-0.8988 (-0.74%)

09:51
02/21/18
02/21
09:51
02/21/18
09:51
Conference/Events
Cooper-Standard management to meet with Roth Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 11

    Mar

LEXEB

Liberty Expedia Holdings

09:50
02/21/18
02/21
09:50
02/21/18
09:50
Hot Stocks
Breaking Hot Stocks news story on Liberty Expedia Holdings  »

Liberty Expedia Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANET

Arista Networks

$249.53

-0.125 (-0.05%)

09:50
02/21/18
02/21
09:50
02/21/18
09:50
Conference/Events
Arista Networks management to meet with KeyBanc »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

  • 26

    Feb

  • 06

    Mar

  • 13

    Mar

  • 14

    Mar

  • 29

    Mar

LEXEB

Liberty Expedia Holdings

09:45
02/21/18
02/21
09:45
02/21/18
09:45
Hot Stocks
Breaking Hot Stocks news story on Liberty Expedia Holdings  »

Liberty Expedia Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:45
02/21/18
02/21
09:45
02/21/18
09:45
General news
Existing Home Sales to be reported at 10:00 »

January Existing Home…

PM

Philip Morris

09:43
02/21/18
02/21
09:43
02/21/18
09:43
Earnings
Philip Morris sees Q1 EPS about 87c, including 3c of favorable currency 

Consensus is 90c.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DVAX

Dynavax

$17.25

0.025 (0.15%)

09:41
02/21/18
02/21
09:41
02/21/18
09:41
Hot Stocks
Dynavax says CDC advisory committee recommends Heplisav-B »

Dynavax announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 26

    Feb

  • 04

    Apr

GRMN

Garmin

$64.86

-0.35 (-0.54%)

, DUST

Direxion Daily Gold Miners Bear 3X ETF

09:40
02/21/18
02/21
09:40
02/21/18
09:40
Options
Unusually active option classes on open February 21st »

Unusual total active…

GRMN

Garmin

$64.86

-0.35 (-0.54%)

DUST

Direxion Daily Gold Miners Bear 3X ETF

STZ

Constellation Brands, also tag STZ.B

PEP

PepsiCo

$109.48

-1.58 (-1.42%)

XRT

S&P Retail Index SPDR

P

Pandora

GM

General Motors

MA

MasterCard

NXPI

NXP Semiconductors

$125.56

7.06 (5.96%)

MCD

McDonald's

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 23

    Feb

  • 26

    Feb

  • 01

    Mar

  • 05

    Mar

  • 08

    Mar

  • 22

    Mar

  • 23

    Mar

  • 27

    Mar

  • 28

    Mar

  • 30

    May

DKS

Dick's Sporting

09:38
02/21/18
02/21
09:38
02/21/18
09:38
Upgrade
Dick's Sporting rating change  »

Dick's Sporting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:35
02/21/18
02/21
09:35
02/21/18
09:35
General news
Treasury 5-year auction outlook: the $35 B sale is the second leg »

Treasury 5-year auction…

LJPC

La Jolla

$33.17

-0.7 (-2.07%)

09:35
02/21/18
02/21
09:35
02/21/18
09:35
Hot Stocks
La Jolla announces treatment of first patient in Giapreza pediatric study »

La Jolla Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

FNF

FNF Group

09:34
02/21/18
02/21
09:34
02/21/18
09:34
Recommendations
FNF Group analyst commentary  »

FNF Group added to Top…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMSC

AMSC

$4.71

0.1 (2.17%)

09:33
02/21/18
02/21
09:33
02/21/18
09:33
Hot Stocks
AMSC announces $10M in D-VAR system orders »

AMSC announced three new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

EXPE

Expedia

$104.10

0.25 (0.24%)

09:32
02/21/18
02/21
09:32
02/21/18
09:32
Recommendations
Expedia analyst commentary  »

Expedia price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Feb

  • 07

    Mar

09:30
02/21/18
02/21
09:30
02/21/18
09:30
General news
PMI Composite Flash Manufacturing â€' Level to be reported at 09:45 »

February PMI Composite…

09:30
02/21/18
02/21
09:30
02/21/18
09:30
General news
PMI Composite Flash â€' Level to be reported at 09:45 »

February PMI Composite…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.